Elipran 20 Tablet

Introduction

Elipran is a medication that contains the active ingredient Eletriptan. It is available under the brand name Elipran. Elipran is primarily used for the treatment of migraines.

Uses

Elipran is prescribed to individuals who suffer from migraines. Migraines are severe headaches that are often accompanied by other symptoms such as nausea, vomiting, and sensitivity to light and sound. This medication helps to relieve the pain and other symptoms associated with migraines, allowing individuals to resume their normal activities.

Dosage and Administration

The dosage of Elipran may vary depending on the severity of the migraine and the individual’s response to the medication. Follow the instructions provided by your healthcare professional. Generally, the recommended starting dose is 40 mg, which may be increased to 80 mg if necessary. The tablet should be swallowed whole with water, and it can be taken with or without food.

Mechanism of Action

Elipran belongs to a class of medications known as selective serotonin receptor agonists. It works by narrowing the blood vessels in the brain and reducing the release of certain chemicals that can cause inflammation and pain. By targeting these specific mechanisms, Elipran helps to alleviate the symptoms of migraines.

Side Effects

Common side effects may include dizziness, fatigue, dry mouth, and nausea. These side effects are usually mild and temporary. However, if you experience any serious side effects such as chest pain, shortness of breath, or severe allergic reactions, seek immediate medical attention.

Drug Interactions

Elipran may interact with certain medications. Inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Some drugs that may interact with Elipran include monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and certain antibiotics. These interactions can increase the risk of side effects or affect the effectiveness of the medication.

Precautions

Before taking Elipran, inform your healthcare professional about any medical conditions you have, including a history of heart problems, high blood pressure, liver or kidney disease, or allergies. This medication should not be used by individuals with certain types of heart conditions. Avoid using Elipran if you have taken other migraine medications within the past 24 hours. Additionally, alcohol consumption should be avoided while taking this medication.

Storage

Elipran should be stored at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take Elipran as soon as you feel a migraine headache coming on, for best results.
• follow the dosage instructions provided by your healthcare professional.
• If your migraine symptoms do not improve or worsen after taking Elipran, consult your healthcare professional.
• Keep a record of your migraine attacks and the effectiveness of Elipran. This information can help your healthcare professional in determining the most appropriate treatment plan for you.
• If you have any concerns or questions about Elipran, do not hesitate to reach out to your healthcare professional for clarification and guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• RELPAX 20mg Film-Coated Tablets. (Health Professionals SmPC) Available at:
• Eletriptan (Drugs.com) [Accessed 3 Jun. 2024] (online) Available at:
• eletriptan hbr tablet (RX) [Accessed 12 Jun. 2024] (online) Available at:
• Eletriptan (MedlinePlus) [Accessed 20 Jun. 2024] (online) Available at:
• [No authors listed] Eletriptan. 2024 Apr 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. [Accessed 2 Jun. 2024] Available at: